Shopping Cart
Remove All
Your shopping cart is currently empty
Antitumor agent-150 (V10) is a breast cancer treatment that functions as a PROTAC degrader of MDM2.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Backorder | Backorder | |
| 50 mg | Inquiry | Backorder | Backorder |
| Description | Antitumor agent-150 (V10) is a breast cancer treatment that functions as a PROTAC degrader of MDM2. |
| In vitro | Antitumor agent-150 (V10) demonstrates considerable tumor inhibitory activity in a TNBC zebrafish model, with a 27.2% inhibition rate at a concentration of 50 μg/mL. At 10 μM, Antitumor agent-150 (V10) induces apoptosis in MDA-MB-231 cells. Additionally, treatment with Antitumor agent-150 (V10) significantly alters the G1 and S phases of MDA-MB-231 cells. |
| Formula | C70H106N8O14S |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.